InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces Record Date for Proposed Fully Back-Stopped $30 Million Rights Offering
03 janv. 2022 17h07 HE | Interpace Biosciences, Inc.
Proceeds to be used to fund the organic growth and prospective product line acquisitions PARSIPPANY, NJ, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”)...
Rome Foundation Releases Clinical Criteria to Better Meet Needs of Patients
29 nov. 2021 09h00 HE | Rome Foundation
RALEIGH, N.C., Nov. 29, 2021 (GLOBE NEWSWIRE) -- The Rome Foundation has published a groundbreaking modification of the Rome IV diagnostic criteria of the Disorders of Gut Brain Interaction (DGBI -...
TIP_link_300x300.jpg
$712.91Mn by 2028 Photomedicine Devices and Technologies Market Size Lead by Photodynamic Therapy (5.3% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
24 nov. 2021 07h05 HE | The Insight Partners
New York, Nov. 24, 2021 (GLOBE NEWSWIRE) -- According to our new research study on Photomedicine Devices and Technologies Market Size, Share, Revenue, Growth, Trends, Forecast to 2028 - COVID-19...
InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces Third Quarter 2021 Financial and Business Results
10 nov. 2021 16h05 HE | Interpace Biosciences, Inc.
 ●Q3 Revenue of $9.5 Million is a 15% Improvement versus Q3 2020 ●Year to Date Revenue of $30.5 Million Up 34% Versus Prior Year ●Second Consecutive Record Cash Collection Quarter ●Significantly...
InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces U.S. PTO Issuance of Patent No. 11,143,657 Titled: Topographic Genotyping for Determining the Diagnosis, Malignant Potential, and Biologic Behavior of Pancreatic Cysts and Related Conditions
28 oct. 2021 08h15 HE | Interpace Biosciences, Inc.
PARSIPPANY, NJ, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG), a fully integrated commercial company that provides clinically relevant...
Vietnam leads the way with SOS Stool Method to diagnose TB
28 oct. 2021 08h00 HE | KNCV Tuberculosis Foundation
Vietnam, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Vietnam is the first country in the world to routinely use an innovative method to diagnose tuberculosis (TB) using stool. The Simple One-Step Stool...
InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces New $7.5 Million Credit Facility with Comerica Bank
15 oct. 2021 09h15 HE | Interpace Biosciences, Inc.
PARSIPPANY, NJ, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced that it, along with its subsidiaries, has entered into a...
Philips introduces next-generation Digital Pathology Suite - IntelliSite - to enhance diagnostic confidence and streamline pathology lab workflows
15 oct. 2021 04h00 HE | Royal Philips
October 15, 2021 Solution offers high quality imaging with multi-site, multi-disciplinary interoperability, artificial intelligence and Laboratory Information System integration, enhancing...
InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces Second Quarter 2021 Financial and Business Results
10 août 2021 16h05 HE | Interpace Biosciences, Inc.
 ●Q2 Revenue of $11.2 Million Surpasses Q1 2021 as Company’s Highest Revenue Quarter  ●Company approaching EBITDA breakeven on Higher Clinical Volume, Revenue, Improved Gross Profit and Operating...
Beyond Celiac Expands Board in Drive Toward a Cure
15 juil. 2021 14h53 HE | Beyond Celiac
Philadelphia, PA, July 15, 2021 (GLOBE NEWSWIRE) -- Beyond Celiac, the leading catalyst for a celiac disease cure in the United States, announced today that Lisa Agdern, executive director,...